Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Diseases × Paclitaxel × Clear all

Phase

Phase 2 3 Phase 3 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Thoracic Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Patient Acceptance of Health Care 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Lung Diseases 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Large Cell 1 Cancer Therapy-related Cardiovascular Toxicity 1 Breast Neoplasm Female 1

Interventions

Carboplatin 2 Vinorelbine 1 Pemetrexed 1 Paclitaxel 1 One-Lung Ventilation 1 Nivolumab 1 Natriuretic Peptide, Brain 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583188 2024-07-19

VIGOR

Galvanize Therapeutics, Inc.

Phase 4 Terminated

Lung Diseases, Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡